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THE effect of nedocromil sodium on the plasma mem-
brane fluidity of polymorphonuclear leukocytes (PMNs)
was investigated by measuring steady-state fluorescence
anisotropy of 1-[4-trimethylammonium-phenyl]-6-phe-
nyl-l,3,5-hexatriene (TMA-DPH) incorporated in the
membrane. Our results show that nedocromil sodium
300 tM significantly decreased membrane fluidity of
PMNs. The decrease in membrane fluidity of PMNs in-
duced by fMLP was abolished in the presence of
nedocromil sodium. These data suggest that nedocromil
sodium interferes with the plasma membranes of PMNs
and modulates their activities.
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Introduction
In response to inflammatory stimuli, a rapid and
often massive influx of polymorphonuclear
leukocytes (PMNs) can be driven to the inflamed
tissues. This is particularly true in the lung, where
PMNs traffic can be facilitated both by a rather thin
barrier separating the alveolar space from the capil-
lary lumen, and by the sequestration of PMNs in the
pulmonary vasculature. Although PMNs are prob-
ably not the dominant cells in asthma, they may
contribute to the inflammatory process underlying
the disease. A series of membrane receptors have
been identified on the surface of PMNs. These
receptors constitute the link between PMNs and their
environment, and modulate PMNs functions, includ-
ing adherence, migration, degranulation, and respi-
ratory burst.
There is little argument that products of activated
PMNs are tissue-damaging. In a variety of experimen-
tal models of inflammation, depletion of PMNs at-
tenuates the intensity of tissue damage. PMNs have
tremendous potential to generate inflammation by
releasing lysosomal enzymes, oxygen reactive spe-
cies, histamine-releasing factor and inflammatory
mediators.
Airway inflammation has emerged as an important
contributor to the mechanisms of asthma. Further-
more, the presence of airway inflammation is present
even in the absence of severe symptoms. In asthmat-
ics, nedocromil sodium has anti-inflammatory prop-
erties in vitro, as evidenced by inhibition of inflam-
matory cell activation and mediators release. In this
study, the effect of nedocromil sodium on membrane
fluidity of PMNs was investigated using fluorescence
technique.
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Materials and Methods
Preparation ofPMNs: Blood samples were obtained
from ten healthy donors and PMNs were isolated
using a Mono-Poly Resolving Medium (ICN
Biomedicals, Milan, Italy) as previously described.
Cells were resuspended in Krebs Ringer Phosphate
solution (KRP), supplemented with 5 mM glucose.
Chemiluminescence measurements: Luminol-ampli-
fled chemiluminescence (CL) was measured in an
AutoLumat LB 953 (Berthold Co., Wilbad, Germany)
and PMNs in the presence or absence of nedocromil
sodium 300 lttM were activated by addition of
N-formyl-methionyl-leucyl-phenylalanine (fMLP)
(Sigma Chemical Co., St Louis, MO, USA) (10.7 M) or
phorbol myristate acetate (PMA) (Sigma Chemical
Co.) 3 x 10-4 M, as previously described. Nedocromil
sodium was kindly donated by Fisons plc, Pharma-
ceutical Division (Loughborough, Leics, UK).
Fluorescence measurements: Steady-state fluores-
cence anisotropy (rs) measurements were performed
at 37C with a Perkin Elmer Spectrofluorimeter MPF-
66, equipped with a Perkin Elmer 7300 Personal
Computer for data acquisition and elaboration, using
1-[4-trimethylammoniumphenyl]-6-phenyl- 1,3,5-
hexatriene (TMA-DPH) (Molecular Probes, Inc.,
Eugene, OR, USA) as hydrophobic fluorescent probe
at a final concentration of 10.6 M as previously de-
scribed. The computer program calculated rs by
using the expression (I- x g)/(Iii +2I+/- x g) where
g is an instrument correction factor, It and are,
respectively, the emission intensities with polarizers
parallel and perpendicular to the direction of polar-
ized light. Labelling was carried out in the dark and
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rs values were determined before and after addition
of nedocromil sodium (300 l.tM).
The significance of values obtained was calculated
using Student’s t-test.
Results
Chemiluminescence studies: When fMLP was added
to PMNs, a bimodal response was obtained. The first
peak appeared after approximately 1 min and the
second peak occurred after 3-5 min. When PMNs
were exposed to fMLP in the presence of nedocromil
sodium (300 l-tM), a significant inhibition of both
peaks was observed (Fig. 1). This inhibition was
dose-dependent (data not shown). When PMNs were
activated with PMA, a peak CL value was obtained
15-17 min after activation. No significant inhibition
was observed in the presence of nedocromil 300 l.tM.
Fluorescence study: The background fluorescence of
PMNs was checked before each measurement and
was less than 0.1% of the fluorescence when TMA-
DPH was added. In basal conditions, without stimu-
lation, the rs of TMA-DPH incorporated in plasma
membrane of PMNs was stable and did not show
significant changes (p > 0.5) for 30 min after addition
of TMA-DPH. In the absence of nedocromil, fMLP
induced a significant and time-dependent increase in
r value (Fig. 2). Nedocromil sodium induced a sig-
nificant (p < 0.001) and stable increase in the r value
(Fig. 3). The addition of fMLP to PMNs treated with
nedocromil sodium abolished the effect of fMLP on
PMNs plasma membrane (data not shown).
Discussion
Nedocromil sodium has been shown to inhibit
chemotaxis of human PMNs induced by zymosan
activated serum, PAF, leukotriene B4 or f/ILP. 1-12
Moreover, it inhibits the respiratory burst of PMNs
stimulated with PAF or fMLP. 12’13
The N-formyl peptide receptor of human PMNs is
an integral membrane protein. Agonist binding to
this chemoattractant receptor results in a variety of
PMNs activities including chemotaxis, adhesion,
superoxide production and secretion of hydrolytic
enzymes.
14
The signal transduction cascade initiated by occu-
pancy of N-formyl peptide receptors is a complex
spatial and temporal orchestration of biochemical
events mediated by specific molecules. Occupancy
of the chemoattractant receptor with ligand results in
the formation of a ligand-receptor complex. This
complex interacts with guanyl nucleotide binding
protein (G), resulting in the formation of activated
G protein, which then activates phospholipase C
(PLC) in the plasma membrane. PLC activation results
in phosphatidylinositol (PI) hydrolysis to generate
1,4-5-inositoltriphosphate (IP3) and diacylglycerol
(DAG). IP3 induces release of Ca2+ from intracellular
stores, which, in concert with DAG, activate and
cause the translocation of intracellular protein kinase
C (PKC) to the plasma membrane. These events
results in phosphorylation of membrane proteins. 14,15
The consequent biochemical events converge in the
assembly and activation of the complex enzymatic
system NADPH-oxidase.
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FIG. 1. Time-course of luminol-amplified CL of PMNs stimulated with fMLP in absence (A) or presence (B) of
nedocromil sodium (300 IM). CL was measured as counts per minute (cpm). Data are the mean of ten samples.
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FIG. 2. Fluorescence anisotropy of TMA-DPH in PMNs plasma membrane before and after addition of fMLP (10 M). fMLP induced a
time-dependent and significant (p < 0.001) increase in value. Data are the mean (+2SD) of ten samples. (*) Addition of fMLP.
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FIG. 3. Fluorescence anisotropy rs of TMA-DPH in PMNs plasma membrane before and after addition of nedocromil sodium (300 pM).
Nedocromil induced a stable and significant (p < 0.001) increase in r, value. Data are the mean (+2SD) of ten samples. (*) Addition of
nedocromil.
There is now evidence to indicate that each integ-
ral membrane protein interacts with its neighbouring
’boundary’ lipids in a specific manner. 16 Because of
the pronounced effect of different lipids on the
operation of several membrane proteins and mem-
brane processes, it is likely that changes in the
microenvironment of membrane proteins, due to
changes in the lateral organization of lipids, could be
used for regulatory purposes. Iv Alterations in the
composition of this lipid boundary may lead to
changes in enzyme activity, as well as to changes in
ligand specificity and affinity, as shown recently for
the vitronectin receptor. TM
Membrane fluidity is a complex physicochemical
feature which depends upon mobility and on the
order of membrane constituents. 19 TMA-DPH has
been widely used for studying membrane structure
and fluidity because of its advantageous structural
and photophysical properties.
2 TMA-DPH incorpo-
rates into the membrane, but remains at the lipid-
water interface region because of its cationic residue.
TMA-DPH rs reflects the packing of membrane lipid
fatty acid chains, and can be related to the order
parameter S, if certain precautions are taken.
21 Lipid
fluidity may be defined as the reciprocal of the lipid
structural order parameter S,
21 and thus an increase of
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TMA-DPH rs value corresponds to a decrease in
membrane fluidity. In our study, it was observed that
nedocromil sodium induced a significant increase in
the rs value ofTMA-DPH in PMNs plasma membrane.
This indicates a decrease in membrane fluidity. To
investigate whether these changes could influence
formyl peptide receptors function, the TMA-DPH rs
value was evaluated after the addition of fMLP to
PMNs incubated with nedocromil sodium. Our re-
suits demonstrate that nedocromil abolished the pre-
viously reported decrease in membrane fluidity in-
duced by fMLP. This is in accordance with the recent
data reported by Peroni et al. which demonstrated
that nedocromil sodium decreases the binding of
fMLP to PMNs. 22
To obtain more evidence that nedocromil sodium
(300 M) can influence plasma membrane activity,
the response of nedocromil-treated PMNs to fMLP
and PMA was investigated. These activators of the
respiratory burst employ different pathways during
the stimulation of PMNs. PMA activates the PKC,
directly bypassing all the previously mentioned bio-
chemical pathways employed by fMLP. 23 Since
nedocromil sodium did not induce changes in PMA
stimulation, it is likely that the changes induced by
nedocromil sodium occur prior to PKC activation.
These results are in accordance with previous studies
that reported no influence of nedocromil on PMNs
activated with PMA, whereas a significant inhibition
on PMNs stimulated with fMLP or PAF occurred. 1,,13
Our data suggest that nedocromil sodium interferes
with the plasma membranes of PMNs, and hence
influences their functional activities.
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